首页>
外国专利>
Treatment of Bladder Cancer Following Detection of Expression Levels of Certain Progression Markers
Treatment of Bladder Cancer Following Detection of Expression Levels of Certain Progression Markers
展开▼
机译:检测某些进展标志物的表达水平后治疗膀胱癌
展开▼
页面导航
摘要
著录项
相似文献
摘要
Disclosed is determining expression levels of protective or harmful markers for bladder cancer prognosis and treatment; particularly, determining the expression levels of protective markers (COL4A3BP, MBNL2, FABP4, NEK1 and SKAP2) and harmful markers (COL4A1, UBE2C, BIRC5, COL18A1, KPNA2, MSN, ACTA2, and CDC25B) and making treatment decisions in consideration of increased or decreased risk of progression based on the marker expression levels.
展开▼